Sign In
Buy VXRT
$0.534
-0.0118 (-2.16%)
At Close: Jul 13, 2026
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
10:20am, Thursday, 26'th Sep 2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biopharmaceutical company focused on the development of oral recombinant vaccines based
Endo Files BLA for CCH With the FDA for Cellulite Candidate (Revised)
04:56am, Tuesday, 10'th Sep 2019
Endo International (ENDP) files BLA for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks.
